Decision ruleHaematology
Revised International Staging System for multiple myeloma (R-ISS)
Combines the ISS with high-risk FISH cytogenetics and LDH to stage newly diagnosed myeloma.
Updated 31 October 2026
When to use it
Patients with newly diagnosed multiple myeloma with FISH on purified plasma cells and LDH available.
What it needs
- Serum β2-microglobulin
- Serum albumin
- High-risk FISH cytogenetics: del(17p), t(4;14) or t(14;16)
- LDH above the upper limit of normal
The points for each answer and the automatic total are in the app.
How to interpret it
The result is read in its clinical context; the app shows it with its units and warnings.
In the app it also calculates: R-ISS stage.
Practical tip
High-risk cytogenetics = del(17p), t(4;14) or t(14;16) by FISH; other lesions (such as 1q gain) do not count in the R-ISS.
2 more practical tips in the app.
Reference
- Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015;33(26):2863-2869.
- Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412-3420.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
